James Kirkpatrick
Family Medicine · Chester, ILNPI 1225471915
Payments from drug & device makers
Across 56 payments — averaging $15.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$246
- Merck$88
- Novo Nordisk$86
- GSK$78
- Sumitomo Pharma America, Inc.$63
- Lilly USA, LLC$44
- plus $266 from 13 others
What the payments were for
- Food & beverage$871100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 16 | $246 |
| Merck | 4 | $88 |
| Novo Nordisk | 5 | $86 |
| GSK | 6 | $78 |
| Sumitomo Pharma America, Inc. | 6 | $63 |
| Lilly USA, LLC | 3 | $44 |
| Dexcom, Inc. | 2 | $37 |
| Johnson & Johnson | 2 | $31 |
| Amarin Pharma, Inc. | 2 | $30 |
| Lundbeck LLC | 1 | $25 |
| Exact Sciences | 1 | $22 |
| Optinose US, Inc. | 1 | $19 |
| Sanofi-aventis U.S. LLC | 1 | $19 |
| Boehringer Ingelheim | 1 | $15 |
| Sanofi Pasteur Inc. | 1 | $15 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $15 |
| Si-bone, Inc. | 1 | $13 |
| Amgen | 1 | $13 |
| Bayer | 1 | $13 |
How this compares
$871 in reported general payments places this provider in the 70th percentile of 4,116 family medicine providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 231 | $160,841 |
| FarxigaDapagliflozin Propanediol | 105 | $77,262 |
| JardianceEmpagliflozin | 89 | $77,131 |
| OzempicSemaglutide | 75 | $74,420 |
| TrulicityDulaglutide | 51 | $57,566 |
| XareltoRivaroxaban | 45 | $43,512 |
| JanuviaSitagliptin Phosphate | 30 | $35,041 |
| Spiriva HandihalerTiotropium Bromide | 42 | $25,361 |
| TradjentaLinagliptin | 14 | $21,552 |
| AbrysvoRsv Vacc, Pref A And Pref B/Pf | 64 | $19,470 |
| Breo ElliptaFluticasone/Vilanterol | 37 | $18,288 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 19 | $15,896 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 20 | $12,917 |
| Combivent RespimatIpratropium/Albuterol Sulfate | 22 | $11,588 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 17 | $10,717 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance, Tradjenta, Combivent Respimat | $15 | $110,271125 claims |
| AstraZenecaFarxiga, Breztri Aerosphere, Symbicort | $246 | $92,424135 claims |
| Novo NordiskOzempic | $86 | $74,42075 claims |
| Lilly USA, LLCTrulicity | $44 | $57,56651 claims |
| Johnson & JohnsonXarelto | $31 | $43,51245 claims |
| GSKBreo Ellipta, Trelegy Ellipta, Shingrix, Arexvy | $78 | $40,41495 claims |
| MerckJanuvia, Dulera | $88 | $38,77041 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $63 | $5,20511 claims |
| Sanofi-aventis U.S. LLCLantus | $19 | $2,16523 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 4,116 family medicine providers in Illinois.
Other family medicine in Chester
- Daniel BruneCreve Coeur$15M
- Ali BajwaSpringfield$5.8M
- John ElsenEvergreen Park$5M
- Manohar JethaniBerwyn$4.9M
- Tiffany NguyenSkokie$3.9M
- Bradley TorphyChicago$3M
- Diana WidicusRochester$2.6M
- Nicholas WeberEureka$2.5M
- Stanley KochMorton$2.3M
- Mark ChristensenNew Lenox$2.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.